Kymera Therapeutics Inc

$45.78
(as of Jun 3, 9:31 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Kymera Therapeutics Inc

Stock Price
$45.78
Ticker Symbol
KYMR
Exchange
NASDAQ

Industry Information for Kymera Therapeutics Inc

Sector
Healthcare
Industry
Biotechnology

Company Description for Kymera Therapeutics Inc

Website
https://www.kymeratx.com
Country
USA
Full Time Employees
208

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Fundamentals for Kymera Therapeutics Inc

Market Capitalization
$2,837,912,320
EBITDA
$-271,670,016
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-3.11
Earnings per Share Estimate Next Year
Profit Margin
Shares Outstanding
65,119,600
Percent Owned by Insiders
2.69%
Percent Owned by Institutions
111.72%
52-Week High
52-Week Low

Technical Indicators for Kymera Therapeutics Inc

50-Day Moving Average
200-Day Moving Average
RSI
75.66
ATR
3.06

Analyst Ratings for Kymera Therapeutics Inc

Strong Buy
14
Buy
3
Hold
3
Sell
0
Strong Sell
0

News About Kymera Therapeutics Inc

Jun 3, 2025, 2:09 PM EST
[Wall Street New York stock exchange stock market] See more.
Jun 3, 2025, 11:14 AM EST
Kymera Therapeutics, Inc. See more.
Jun 3, 2025, 11:06 AM EST
Kymera Therapeutics' (KYMR) STAT6 degrader KT621 showed promising phase 1 results, marking a key de- See more.
Jun 3, 2025, 2:22 AM EST
We recently published a list of These 10 Stocks Blew Past Expectations. See more.